Nippon Chemiphar Co., Ltd. (TYO:4539)
Japan · Delayed Price · Currency is JPY 1,768.00
+18.00 (1.03%)
Feb 13, 2026, 3:30 PM JST
Nippon Chemiphar Market Cap
Nippon Chemiphar has a market cap or net worth of 6.38 billion as of February 13, 2026. Its market cap has increased by 18.25% in one year.
Market Cap
6.38B
Enterprise Value
17.03B
Revenue
32.52B
Ranking
n/a
PE Ratio
11.71
Stock Price
1,768.00
Market Cap Chart
Since January 14, 1992, Nippon Chemiphar's market cap has decreased from 34.36B to 6.38B, a decrease of -81.44%. That is a compound annual growth rate of -4.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 6.31B | 10.41% |
| Dec 30, 2025 | 5.72B | 4.27% |
| Dec 30, 2024 | 5.48B | -3.80% |
| Dec 29, 2023 | 5.70B | -4.67% |
| Dec 30, 2022 | 5.98B | -17.63% |
| Dec 30, 2021 | 7.26B | -8.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fuso Pharmaceutical Industries,Ltd. | 20.28B |
| Pharma Foods International | 19.28B |
| Taiko Pharmaceutical | 14.82B |
| Wakamoto Pharmaceutical | 10.86B |
| Morishita Jintan | 9.43B |
| Solasia Pharma K.K. | 7.90B |
| Cyfuse Biomedical K.K. | 6.83B |
| MedRx | 6.71B |